Overall, this trial was designed to precisely determine the dose-response relationship, efficacy, and safety of Cagrilintide compared with placebo and liraglutide, while employing advanced statistical methods to ensure reliable interpretation of treatment effects under both ideal and real-world adherence conditions
Available in 1 mL vials (5 mg total) and 2 mL vials (10 mg total)
As noted by Wissam G., secondary endpoints included the percentage of patients attaining 5, 10, 15, and 20% weight loss, along with improvements in metabolic, cardiovascular, and comorbidities after 12 months of follow-up
Study Duration & Experimental Cycles Animal models often run in short cycles, typically between 26 weeks, with follow-up periods used to evaluate recovery or cellular responses
Caspase-3 activity assay Both hepatocytes and liver tissues were lysed on ice with lysis buffer containing protease inhibitors, and the proteins were collected
Your body may need a few weeks time to get used to the drug